Carregant...
Combined therapies that induce senescence and stabilize p53 block melanoma growth and prompt antitumor immune responses
We recently demonstrated that dual therapy combining AURKA and MDM2 antagonists is effective against melanoma in preclinical settings. Notably, besides inducing apoptosis, this regimen led to tumor senescence and stimulated the host's antitumor immune defenses. Treatments leveraging both cancer...
Guardat en:
| Publicat a: | Oncoimmunology |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4570092/ https://ncbi.nlm.nih.gov/pubmed/26405565 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1009299 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|